Thomas A. MCCOURT - 30 Jun 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Ronald Silver, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
30 Jun 2022
Net transactions value
-$231,125
Form type
4
Filing time
05 Jul 2022, 16:05:34 UTC
Previous filing
25 May 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale $231,125 -19,959 -2.5% $11.58 778,922 30 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.